Vimarsana
Biggest News Aggregation in the World

Peter Choo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peter Choo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peter Choo Today - Breaking & Trending Today

Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology - Vimarsana News

Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology

29.01.2024 - The Company now has exclusive rights to a Malaysia, US and China patentSINGAPORE, Jan. 29, 2024 (GLOBE NEWSWIRE) - CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on ... Seite 1

CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update - Vimarsana News

CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update

Conference call webcast is scheduled for November 22 at 9 a.m. ET. SINGAPORE, Nov. 17, 2023 /PRNewswire/ -- CytoMed Therapeutics Limited , a Singapore-based biopharmaceutical company focused on...

CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update - Vimarsana News

CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update

Conference call webcast is scheduled for November 22 at 9 a.m. ET. SINGAPORE, Nov. 17, 2023 /PRNewswire/ -- CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or "Company"), a Singapore-based biopharmaceutical company focused on harnessing its proprietary technologies to develop novel donor-derived cell-based allogeneic immunotherapies for the treatment of various cancers, today announced its first half of 2023 financial results...

Kenpo Karate - Everything You Need To Know - Vimarsana News

Kenpo Karate - Everything You Need To Know

Kenpo Karate is one of the most effective offshoots of Karate that has been developed. Known for its practicality and adaptability to be used in self-defense

CytoMed Therapeutics Adds to its Intellectual Portfolio After Securing Chinese Patent for its Licensed iPSC-Based Technology - CytoMed Therapeutics (NASDAQ:GDTC) - Vimarsana News

CytoMed Therapeutics Adds to its Intellectual Portfolio After Securing Chinese Patent for its Licensed iPSC-Based Technology - CytoMed Therapeutics (NASDAQ:GDTC)

SINGAPORE / ACCESSWIRE / October 24, 2023 / CytoMed Therapeutics Limited (NASDAQ:GDTC) ("CytoMed" or "the Company"), a Singapore biopharmaceutical company focused on utilizing its licensed proprietary